Investors

Titan Medical Inc. is a publicly-held medical device company headquartered in Toronto, Ontario, with shares listed on the Toronto Stock Exchange (TMD) and Nasdaq (TMDI). Titan is focused on the design and development of surgical technologies for application in robotic single access surgery. Design and development activities are directed and performed by the company’s wholly owned U.S. subsidiary, Titan Medical USA Inc. based in Chapel Hill, North Carolina. The Enos™ surgical system, by Titan Medical, is being developed to become the new standard of care in robotic single access surgery with dual 3D and 2D high-definition vision systems, multi-articulating instruments, and an ergonomic surgeon workstation. With the Enos system, Titan intends to initially pursue gynecologic surgical indications. The Enos system is designed with the goals of improving clinical performance, ease of use, operating room efficiency and hospital economics. Certain of Titan’s robotic assisted surgical technologies and related intellectual property have been licensed to Medtronic plc, while retaining world-wide rights to commercialize the technologies for use with the Enos system.

Investor Presentation

Download PDF

Governance

Position Description

Majority Voting Policy

Insider Trading Policy

Corporate Governance and Nominating Charter

Code of Conduct

Board of Director’s Mandate

Compensation Committee Charter

Audit Committee Charter

Titan-Articles-of-Amalgamation

Titan-Medical-By-Law-Amendment

Titan-Medical-Inc.-Amended-and-Restated-By-Law-No.-1

Financial Events

Titan Medical Q3 2020 Highlights

Titan Video of Chapel Hill Tech Hub
Shown at Annual General Meeting

Titan at LD Micro: The LD 500 Conference

Titan Presents at H.C. Wainwright 22nd Annual Global Investment Conference

Filings

SEDAR Filings – Link to search
results on SEDAR

EDGAR Filings– Link to search
results on EDGAR  

Archived Press Releases

Titan Medical Announces Intellectual Property Portfolio Expansion with Issuance of Robotic Surgery Patents Related to Camera and System Control

Titan Medical Inc. to Present at the H.C. Wainwright Virtual Conference

Titan Medical Reports Second Quarter 2020 Financial Results

Titan Medical Confirms Receipt of Deficiency Notice From Nasdaq

Titan Medical Reports Design Enhancements to Single-Port Robotic Surgical Instruments on Product Development Resumption

Titan Medical to Present at the Society of Robotic Surgery 2020 World Robotic Symposium

Titan Medical Issues Shareholder Update Letter

Titan Medical Promotes Globally Recognized Intellectual Property Strategy Leader to Vice President and General Counsel

Titan Medical Reports Full Compliance with Nasdaq Listing Criteria

Titan Medical Establishes U.S. Subsidiary to Strengthen its Research and Product Development Activities

Titan Medical Announces Closing of US$18.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Titan Medical Appoints Phillip L. McStotts, CPA, CGMA to Board of Directors

Titan Medical Announces Settlement of Pending Litigation With Naglreiter Consulting, LLC 

Titan Medical Announces US$18.0 Million Registered Direct Offering Priced At-the-Market

Titan Medical Announces Development and License Agreements With Medtronic and Senior Secured Loan

Titan Medical Receives Nasdaq Delisting Notification and Discloses Plans for Appeal

Titan Medical Reports First Quarter 2020 Financial Results

Titan Medical Announces Closing of US$2.0 Million Registered Direct Offering

Titan Medical Announces US$2.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Titan Medical and Its Primary Product Development Supplier Agree to Payment Plan for Outstanding Amounts and Resumption of Development Services

Titan Medical Announces $1.5 Million Senior Secured Loan Facility With a Leading Global Medical Technology

Titan Medical Reports 2019 Financial Results

Titan Medical Announces Closing of US$1.2 Million Registered Direct Offering

Titan Medical Expands and Strengthens Global Intellectual Property Portfolio With Issuance of Robotic Surgery Patents

Titan Medical Announces US$1.2 Million Registered Direct Offering

Titan Medical Announces Departure of Director Domenic Serafino

Titan Medical Issues Letter to Shareholders

Titan Medical Receives ISO 13485 Certification, Provides Update on Fourth Quarter Milestones

Titan Medical and Cambridge Design Partnership Announce Expanded Engagement for Robotic Instrument Development